Related Experiment Videos
Ocular herpes simplex infection: pathogenesis and current therapy.
1Department of Ophthalmology, Mayo Clinic Jacksonville, FL 32224.
Mayo Clinic Proceedings
|November 1, 1988
Summary
Ocular herpes simplex virus (HSV) infections present variably due to infection site, host immunity, and treatment effects. Understanding the viral genome and host response aids in classifying and managing this complex eye disease.
Area of Science:
- Ophthalmology
- Virology
- Immunology
Background:
- Ocular herpes simplex disease exhibits diverse clinical presentations and recurrences.
- Pathophysiology involves viral-host interactions, immunologic events, tissue damage, and antiviral drug toxicity.
- Recent research elucidates the herpes simplex virus (HSV) genome's role in disease virulence.
Purpose of the Study:
- To present a clinical model and hypothesis for ocular HSV pathophysiology.
- To propose a classification system for ocular herpes simplex based on disease manifestations and host response.
- To outline a management plan for ocular HSV informed by disease process knowledge.
Main Methods:
- Literature review and synthesis of laboratory and clinical research findings.
- Development of a working hypothesis on complex pathophysiologic features.
- Analysis of viral genome studies concerning virulence and pathogenicity.
Main Results:
- Established a clinical model for ocular HSV.
- Defined the viral genome's contribution to pathogenicity.
- Proposed a classification system integrating viral disease and host response.
- Identified key factors for medical and surgical management strategies.
Conclusions:
- Ocular HSV management requires considering epithelial integrity and active viral presence.
- A nuanced understanding of viral and host factors is crucial for effective treatment.
- The proposed classification and management plan offer a framework for clinical practice.